Evidence map›Paper›PMID 36836283›Full record

ArticleJournal of fungi (Basel, Switzerland)2023

Functional Expression of Recombinant

Stephanie Toepfer, Michaela Lackner, Mikhail V Keniya, Brian C Monk

Open access · goldAbstract read
In one paragraph

Article in Journal of fungi (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. The molecular basis of intrinsic resistance to azoles inAntimicrobial agents and chemotherapy · 2026
    Article
  3. Review
  4. Functional characterization ofFrontiers in microbiology · 2026
    Article
  5. Article
  6. Multidrug efflux pumps and innate azole resistance of Mucor lusitanicus.The Journal of antimicrobial chemotherapy · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Overcoming Drug Resistance in a ClinicalAntibiotics (Basel, Switzerland) · 2023
    Article
  14. Clorgyline Analogs Synergize with Azoles against Drug Efflux inJournal of fungi (Basel, Switzerland) · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 3 countries.

Stephanie ToepferFaculty of Dentistry, Sir John Walsh Research Institute, University of Otago, Dunedin 9016, New Zealand.
Michaela LacknerInstitute of Hygiene and Medical Microbiology, Medical University of Innsbruck, Schöpfstrasse 41, 6020 Innsbruck, Austria.ORCID 0000-0001-9073-2886
Mikhail V KeniyaFaculty of Dentistry, Sir John Walsh Research Institute, University of Otago, Dunedin 9016, New Zealand.
Brian C MonkFaculty of Dentistry, Sir John Walsh Research Institute, University of Otago, Dunedin 9016, New Zealand.ORCID 0000-0003-2264-3480
University of Otago · NZHackensack Meridian Health · USInnsbruck Medical University · AT

Funding

Health Research Council of New Zealand 19/397Sir John Walsh Research Institute Doctoral Fellowship to ST
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

amino acid substitutionsazole resistanceCandida auriscandida infectioncandidiasisdrug screeningemerging pathogenshuman pathogenic fungimultidrug resistanceyeast heterologous expression platform

Identifiers

PMID36836283
PMCPMC9960696
OpenAlexW4318474936

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.